Potential of FTIR spectroscopy applied to exosomes for Alzheimer’s disease discrimination: a pilot study

Alzheimer's disease (AD) diagnosis is based on psychological and imaging tests but can also include monitoring cerebrospinal fluid (CSF) biomarkers. However, CSF based-neurochemical approaches are expensive and invasive, limiting their use to well-equipped settings. In contrast, blood-based bio...

ver descrição completa

Detalhes bibliográficos
Autor principal: Soares Martins, Tânia (author)
Outros Autores: Magalhães, Sandra (author), Rosa, Ilka Martins (author), Vogelgsang, Jonathan (author), Wiltfang, Jens (author), Delgadillo, Ivonne (author), Catita, José António Morais (author), da Cruz e Silva, Odete A.B. (author), Nunes, Alexandra (author), Henriques, Ana Gabriela (author)
Formato: article
Idioma:eng
Publicado em: 2022
Assuntos:
Exosomes
Blood
Serum
Alzheimer’s disease
Biomarker
Diagnosis
Texto completo:http://hdl.handle.net/10284/10680
País:Portugal
Oai:oai:bdigital.ufp.pt:10284/10680

Texto Completo

http://hdl.handle.net/10284/10680

Registros relacionados